Find Therapeutics

Saint-laurent, Canada Founded: 2017 • Age: 9 yrs
Developer of precision targeted therapies for autoimmune diseases

About Find Therapeutics

Find Therapeutics is a Healthcare company based in Saint-laurent (Canada) founded in 2017. Developer of precision targeted therapies for autoimmune diseases. Find Therapeutics has raised $8.1 million across 2 funding rounds from investors including Domain Therapeutics, adMare BioInnovations and PeptiMimesis. Its chief executive, as recorded, is Philippe Douville. Find Therapeutics offers products and services including FTX-101 and Science Platform. Its focus areas include Life Sciences, Ophthalmology, Drugs and Diversified.

Company details

Find Therapeutics was founded in 2017 as a biotechnology company focused on autoimmune disease treatments. Precision targeted therapies are designed through the specific targeting of membrane receptors. Development and discovery programs form the core pipeline, aimed at addressing unmet needs in autoimmune conditions. Operations center on advancing these therapeutic candidates in the pharmaceutical sector, with leadership provided by CEO Philippe Douville.

  • Headquarters Saint-laurent, Canada
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website findtherapeutics.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $8.1M (USD)

    in 2 rounds

  • Latest Funding Round
    $8.1M (USD), Series A

    Sep 2024

  • Investors

Products & Services of Find Therapeutics

Find Therapeutics offers a comprehensive portfolio of products and services, including FTX-101 and Science Platform.

FTX-101
Therapeutic Drug

Modulates membrane receptors to treat autoimmune diseases effectively.

Science Platform
Research Tool

Enables innovative chemistry for designing therapies in drug discovery.

Funding Insights of Find Therapeutics

Find Therapeutics has successfully raised a total of $8.1M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8.1 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $8.1M
  • Total Rounds 2
  • Last Round Series A β€” $8.1M
  • Investors Count 5

All 2 funding rounds of Find Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024$8.1MSeries A–Invest Quebec
Jun 2020Seed–CTI Life Sciences Fund, adMare BioInnovations
–
Valuation history

5 investors in total: 5 institutional.

Investors in Find Therapeutics

Find Therapeutics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Domain Therapeutics, adMare BioInnovations and PeptiMimesis.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments are made in life sciences companies.
ctisciences.comMontreal, Canada
Business guidance for corporate companies and startups
investquebec.comQuebec City, Canada
Biopharma consulting services are provided to clients by adMare BioInnovations.
2019admarebio.comVancouver, Canada
GPCR-targeted drug candidates for immuno-oncology and inflammation are developed.
2008domaintherapeutics.comStrasbourg, France
Transmembrane therapeutic peptides are developed for oncology and immune diseases.
2015peptimimesis.comIllkirch Graffenstaden, France
Premium access

Investor details for Find Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Find Therapeutics

3 people are tracked at Find Therapeutics (3 in leadership).

NameRoleGroup
Philippe Douville
CEOLeadership
Frédéric Lemaître Auger
Director And Chairman Of Audit CommitteeLeadership
Laurence Terrisse Rulleau
DirectorLeadership
Premium access

Complete people profiles for Find Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Find Therapeutics

3 dated milestones of Find Therapeutics across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Find Therapeutics is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $8.1M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Find Therapeutics

Premium access

Complete news archive for Find Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Find Therapeutics

Find Therapeutics was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Find Therapeutics is headquartered in Saint-laurent, Canada. It is registered at Saint-laurent, Quebec, Canada.

Philippe Douville is the CEO of Find Therapeutics, as recorded in our data.

Find Therapeutics is a funded company, having raised a total of $8.1M across 2 funding rounds to date.

Find Therapeutics was founded in 2017 as a biotechnology company focused on autoimmune disease treatments. Precision targeted therapies are designed through the specific targeting of membrane receptors. Development and discovery programs form the core pipeline, aimed at addressing unmet needs in autoimmune conditions. Operations center on advancing these therapeutic candidates in the pharmaceutical sector, with leadership provided by CEO Philippe Douville.

Find Therapeutics offers FTX-101 and Science Platform.

Find Therapeutics has 5 investors. Key investors include Domain Therapeutics, adMare BioInnovations, PeptiMimesis, Invest Quebec, and CTI Life Sciences.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available